What is the coverage and typical dosage of doxycycline (antibiotic) for bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxycycline Antimicrobial Coverage and Dosing

Antimicrobial Spectrum

Doxycycline provides broad-spectrum coverage against gram-positive cocci, gram-negative bacteria, atypical pathogens, and select intracellular organisms, making it a versatile first-line agent for multiple bacterial infections. 1, 2

Specific Bacterial Coverage:

  • Gram-positive organisms: Streptococci, staphylococci (including some MRSA strains when minocycline unavailable), though vancomycin-resistant enterococci are not reliably covered 3, 4

  • Gram-negative organisms: Excellent activity demonstrated with 93.1% collective susceptibility across common isolates, including many Enterobacteriaceae and Neisseria gonorrhoeae (though resistance increasing) 4, 5

  • Atypical pathogens: Chlamydia trachomatis (first-line agent), Mycoplasma pneumoniae, Mycoplasma genitalium, and other respiratory atypicals 2, 3, 6

  • Intracellular organisms: Rickettsia species, Borrelia burgdorferi (Lyme disease), Ehrlichia/Anaplasma phagocytophilum, Coxiella burnetii 7, 3, 8

  • Other pathogens: Plasmodium falciparum (malaria prophylaxis/treatment as combination therapy), Bacillus anthracis (anthrax), select protozoa 9, 8

Standard Treatment Dosing by Indication

Sexually Transmitted Infections (Treatment):

  • Chlamydia trachomatis: 100 mg orally twice daily for 7 days 2
  • Syphilis (penicillin-allergic patients): 100 mg orally twice daily for 14-28 days depending on stage 2
  • Pelvic inflammatory disease: 100 mg orally/IV twice daily as part of combination therapy 6

Respiratory Tract Infections:

  • Community-acquired pneumonia (atypical): 100 mg orally twice daily for 7-10 days 3, 8
  • Acute exacerbations of chronic bronchitis: 100 mg orally twice daily for 5-7 days 8

Tick-Borne Diseases:

  • Human granulocytic anaplasmosis (HGA): 100 mg orally or IV twice daily for 10 days in adults; 4 mg/kg/day divided twice daily (max 100 mg/dose) in children ≥8 years 7
  • Lyme disease (early localized): 100 mg orally twice daily for 10-21 days 7

Skin and Soft Tissue Infections:

  • Animal/human bites: 100 mg orally twice daily for 7-10 days, provides excellent coverage against Pasteurella multocida and Eikenella corrodens 7
  • Erysipeloid: 500 mg penicillin preferred, but doxycycline 100 mg twice daily is alternative 7

Multidrug-Resistant Infections:

  • MDR gram-negative bacteria: 100 mg IV or orally twice daily, showing 81.3% clinical improvement and 87% microbiologic cure in ventilator-associated pneumonia 5
  • Particularly effective against isolates resistant to azithromycin (93.5% susceptibility), amoxicillin (75.9%), and cefuroxime (64.8%) 4

Prophylactic Dosing Regimens

STI Post-Exposure Prophylaxis (Doxy PEP):

For MSM and transgender women with ≥1 bacterial STI in past 12 months: 200 mg single dose within 72 hours after condomless oral, vaginal, or anal sex (maximum 200 mg per 24 hours). 7, 1, 9, 2

  • Reduces syphilis and chlamydia by >70%, gonorrhea by ~50% 2
  • Take as soon as possible post-exposure, ideally within hours 1, 9
  • Evidence insufficient for cisgender women, heterosexual men, transgender men, or nonbinary persons 1
  • Reassess need every 3-6 months with concurrent STI screening at all exposure sites 7, 1, 9

Lyme Disease Prevention:

  • Single 200 mg dose within 72 hours of tick removal when: adult/nymphal Ixodes scapularis tick attached ≥36 hours AND local tick infection rate with Borrelia burgdorferi ≥20% 1

Malaria Prophylaxis:

  • 100 mg orally once daily starting 1-2 days before travel, continuing throughout exposure, and for 4 weeks after leaving malarious area 9

Anthrax Post-Exposure:

  • Adults: 100 mg orally twice daily for 60 days 9
  • Children <100 lbs: 2.2 mg/kg orally twice daily for 60 days 9
  • Children ≥100 lbs: Adult dosing 9

Critical Administration Instructions

Take doxycycline with a full glass of water (≥200 mL) on a full stomach with non-dairy food, and remain upright for at least 1 hour to prevent esophageal ulceration. 7, 1, 9

  • Separate from dairy products, antacids, calcium, iron, magnesium, or sodium bicarbonate by at least 2 hours before AND after dosing to prevent chelation and treatment failure 7, 1, 9
  • Food does not significantly impair absorption (unlike first-generation tetracyclines), making it more convenient 3
  • Long half-life (~12 hours) allows once or twice daily dosing 2, 3

Common Pitfalls and Precautions

Dosing Errors:

  • Never exceed 200 mg doxycycline in 24 hours for STI prophylaxis, even with multiple sexual encounters 1, 9
  • Do not use in children <8 years except for life-threatening infections (HGA, anthrax) due to dental staining risk 7, 9
  • No dose adjustment needed in renal insufficiency, but avoid in severe hepatic dysfunction 3, 8

Side Effects to Counsel:

  • Photosensitivity: Recommend sun protection, avoid tanning beds 7, 1, 9
  • Esophagitis/esophageal ulceration: Prevented by upright positioning for 1 hour post-dose 7, 1, 9
  • Gastrointestinal intolerance: Nausea, vomiting, diarrhea—taking with food mitigates this 7, 2
  • Chronic alcohol consumption may reduce serum levels and efficacy 1

Drug Interactions:

  • Review all medications including over-the-counter products for interactions 7
  • No clinically significant interactions with gender-affirming hormonal therapy 7
  • Separate from antacids and supplements as noted above 7, 1, 9

Resistance Considerations:

  • Increasing N. gonorrhoeae resistance limits doxycycline as first-line monotherapy for gonorrhea 2
  • Potential for antimicrobial resistance development in commensal organisms and other pathogens with prolonged prophylactic use—ongoing surveillance needed 7, 2
  • Despite concerns, resistance rates remain relatively low in Germany and other regions for common pathogens 8

References

Guideline

Doxycycline Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Doxycycline Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tetracyclines.

The Medical clinics of North America, 1995

Research

Doxycycline in the management of sexually transmitted infections.

The Journal of antimicrobial chemotherapy, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Doxycycline--the forgotten antibiotic].

Medizinische Klinik (Munich, Germany : 1983), 2000

Guideline

Doxycycline Prophylactic Dosing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.